This revealed that the degree of CENPI mRNA overexpression correlated with clinical outcome, as luminal A tumors, which have the most favorable prognosis, show the lowest degree of overexpression, while the most malignant, basal-like breast cancers show the highest level of CENPI overexpression (Figure 1B, top). The gene discussed is CENPI; the disease is breast cancer.